ISSN: 1449-2288International Journal of Biological Sciences
Global reach, higher impact
Int J Biol Sci 2024; 20(15):6279-6280. doi:10.7150/ijbs.87837 This issue Cite
Erratum
Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway: Erratum
Yadong Liu1,2,5*, Huiyan Lv3*, Xingyi Li4*, Jiannan Liu5, Song Chen5, Yaodong Chen6, Yinshan Jin5, Ruihua An5, Shiliang Yu5 
, Zhigang Wang1,2
1. Institute of Ultrasound Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
2. State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing 400016, China.
3. Department of Nephrology, The First Affiliated Hospital of Harbin Medical University, No.23 You Zheng Street, Harbin 150001, Heilongjiang, China.
4. Department of Ultrasonic Imaging, Ningbo First Hospital, The Affiliated Hospital of Ningbo University, Ningbo, China.
5. Department of Urology, The First Affiliated Hospital of Harbin Medical University, No.23 You Zheng Street, Harbin 150001, Heilongjiang, China.
6. Department of Ultrasonic Imaging, First Clinical Medical College, Shanxi Medical University, Taiyuan, 030001, Shanxi Province, China.
*These authors contributed equally to this work.
Citation:
Liu Y, Lv H, Li X, Liu J, Chen S, Chen Y, Jin Y, An R, Yu S, Wang Z. Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway: Erratum. Int J Biol Sci 2024; 20(15):6279-6280. doi:10.7150/ijbs.87837. https://www.ijbs.com/v20p6279.htm
Other stylesCorrected-article in Int J Biol Sci, Volume 17, 3522
In the original version of our article, there was an error in Figure 2A and 2B. Specifically, the main reasons were improper gating during flow data analysis and too few cells collected in the last two groups. Figure S1 is a statistical diagram of apoptosis results. We checked the original data again and made sure that the conclusion of the article was not affected by the error. In this regard, all authors have agreed to the erratum, and we apologize for any inconvenience caused by the negligence in our work.
The correct figures are provided in the following Figure A and Figure B.
Figure A
Correct image of Figure 2.
Figure B
Correct image of Figure S1B.
Author contact
Corresponding authors: Zhigang Wang, E-mail: 303507cqmu.edu.cn; Shiliang Yu, E-mail: yushiliangedu.cn.
Published 2024-12-1
Citation styles
APA
Liu, Y., Lv, H., Li, X., Liu, J., Chen, S., Chen, Y., Jin, Y., An, R., Yu, S., Wang, Z. (2024). Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway: Erratum. International Journal of Biological Sciences, 20(15), 6279-6280. https://doi.org/10.7150/ijbs.87837.
ACS
Liu, Y.; Lv, H.; Li, X.; Liu, J.; Chen, S.; Chen, Y.; Jin, Y.; An, R.; Yu, S.; Wang, Z. Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway: Erratum. Int. J. Biol. Sci. 2024, 20 (15), 6279-6280. DOI: 10.7150/ijbs.87837.
NLM
Liu Y, Lv H, Li X, Liu J, Chen S, Chen Y, Jin Y, An R, Yu S, Wang Z. Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway: Erratum. Int J Biol Sci 2024; 20(15):6279-6280. doi:10.7150/ijbs.87837. https://www.ijbs.com/v20p6279.htm
CSE
Liu Y, Lv H, Li X, Liu J, Chen S, Chen Y, Jin Y, An R, Yu S, Wang Z. 2024. Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway: Erratum. Int J Biol Sci. 20(15):6279-6280.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.